Sixth Annual RNAi Roundtable Series - TTRsc02 on Monday next week | ALNY Message Board Posts

Alnylam Pharmaceuticals

  ALNY website

ALNY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34685 of 34718  at  9/12/2019 9:31:47 AM  by

Steve_382


 In response to msg 34684 by  evernewbliss
view thread

Re: Sixth Annual RNAi Roundtable Series - TTRsc02 on Monday next week

 JM actually talked a quite bit about plans for Vutrisiran at the MS conference. He suggested that some patients will likely switch to it, but thought that some would stay on Patisiran. My guess is most will switch, just because of the dosing convenience.
 
Starting around the 15 minute mark or so. 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 77
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
34688 Re: Sixth Annual RNAi Roundtable Series - TTRsc02 on Monday next week evernewbliss 2 9/12/2019 1:55:03 PM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...